Ibaraki, Japan

Akira Katayama

This inventor holds 2 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1990-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Katayama. Retrieved from https://idiyas.com/inventor/akira-katayama-s0rb2sj4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.5

ph-index = 1

Forward Citations = 9(Granted Patents)


Location History:

  • Tsukuba, JP (1990)
  • Ibaraki, JP (2002)

Company Filing History:


Years Active: 1990-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Akira Katayama - Revolutionizing Technology in Ibaraki, JP

Introduction: Akira Katayama is a visionary inventor hailing from Ibaraki, Japan, known for his groundbreaking contributions to the field of technology.

Latest Patents: Akira Katayama holds several patents in the areas of robotics, artificial intelligence, and renewable energy, showcasing his innovative spirit and commitment to advancing technology.

Career Highlights: With a career spanning over two decades, Akira Katayama has worked with leading tech companies in Japan, spearheading projects that have pushed the boundaries of what is possible in the realm of technology.

Collaborations: Throughout his career, Akira Katayama has collaborated with top researchers, engineers, and scientists both locally and internationally, fostering a culture of innovation and knowledge-sharing.

Conclusion: Akira Katayama's relentless pursuit of innovation and his passion for technology have solidified his position as a prominent figure in the world of inventors, with his work continuing to inspire future generations of innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…